IL10 and cancer: Induction of regulatory B cell (Breg) phenotypes, characterized by IL-10 (Interleukin-10), TGFβ (Transforming Growth Factorβ), PD-1 and PD-L1 (Programmed death ligand 1) expression, may be important components of immune responses in models of cancer and in patients.7